Oxybutynin Chloride
Product Images NDC 50090-4728

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 50090-4728). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904728)

Oxybutynin Chloride extended-release tablet label by A-S Medication Solutions. The label displays the NDC 50090-4728-0, product number 6865-0, and package of 90 tablets. Storage instructions specify 68 to 77 degrees Fahrenheit, protected from moisture and light. Dispensing is Rx only.*

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 1)

Chemical structure diagram of Oxybutynin Chloride, showing its molecular composition including functional groups and hydrochloride ion.*

FDA Label Image

Figure 1 (Oxybutynin Chloride Extended Release Tablets Usp 2)

A line graph depicting mean plasma R-oxybutynin concentration (ng/mL) over 24 hours. It compares oxybutynin chloride ER tablets 10 mg once daily (QD) and oxybutynin 5 mg three times daily (TID). The x-axis shows time in hours, and the y-axis shows concentration, with error bars indicating variability.*

FDA Label Image

Figure 2 (Oxybutynin Chloride Extended Release Tablets Usp 3)

A line graph showing mean R-Oxybutynin plasma concentration (ng/mL) over time (hours), with data points plotted from 0 to 24 hours. The y-axis ranges from 0.0 to 2.0 ng/mL, and error bars indicate variability around each mean concentration value.*

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 4)

A horizontal error bar chart comparing Oxybutynin Chloride and Placebo. The chart has a numeric scale from -40 to 40. Oxybutynin Chloride's data point is centered around approximately -20 with error bars extending left and right, while Placebo's data point is centered near 0, also with horizontal error bars.*

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 5)

A horizontal tolerance interval plot showing two labeled data points: Oxybutynin Chloride and oxybutynin. Each point has error bars extending horizontally. The x-axis ranges from -40 to 40 in unspecified units. The plot compares the values or measurements associated with these two labels.*

FDA Label Image

1 (Oxybutynin Chloride Extended Release Tablets Usp 6)

A horizontal scatter plot with error bars showing data for 'Oxybutynin Chloride' and 'oxybutynin'. The x-axis ranges from -40 to 40, with both data points positioned left of zero, around -20 to -10. Exact variable names and values are not fully clear from the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.